PQ 1461
1461. Deputy Emer Currie asked the Minister for Health if he will direct the HSE to overrule the recent recommendation from the National Centre for Pharmacoeconomics and make pluvicto available for reimbursement to eligible patients; if he acknowledges the urgent need for access to this treatment for cancer patients in the healthcare system; and if he will take into account that pluvicto has already been approved and is in use for patient care in several European countries and certain NHS trusts in the UK. [46918/24]
Introduced
22 January 2025
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
22 January 2025
Summary
1461. Deputy Emer Currie asked the Minister for Health if he will direct the HSE to overrule the recent recommendation from the National Centre for Pharmacoeconomics and make pluvicto available for reimbursement to eligible patients; if he acknowledges the urgent need for access to this treatment for cancer patients in the healthcare system; and if he will take into account that pluvicto has already been approved and is in use for patient care in several European countries and certain NHS trusts in the UK. [46918/24]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 22 January 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2025-01-22/1461/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2025-01-22/pq_1461